Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Wainwright Conference
View:
Post by PezDalatoYou on Mar 02, 2021 8:22am

Wainwright Conference

Glad they gave a week's notice. I *may* be able to shuffle my schedule to listen in live. The Kellum effect is making a difference already. ; ) Spectral Medical to Participate at the Upcoming H.C. Wainwright Global Life Sciences Conference MAR 2, 2021 TORONTO, CANADA March 2, 2021 Spectral Medical Inc. (Spectral or the Company) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (Dialco), today announced that Spectrals executive management team, including Dr. Paul Walker, President and CEO, Chris Seto, COO & CFO, and Dr. John Kellum, CMO, will be participating at the H.C. Wainwright Global Life Sciences Conference which will be held virtually on March 9-10, 2021. A link to the presentation will be available under Events, Webcasts and Presentations in the investors section of Spectrals website at 7:00 a.m. ET, Tuesday, March 9, 2021 for a limited time. About Spectral Spectral is a Phase III company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, T Spectral is a Phase III company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Companys Endotoxin Activity Assay (EAA), the only FDA cleared diagnostic for the risk of developing sepsis. PMX is approved for therapeutic use in Japan and Europe, and has been used safely and effectively on more than 200,000 patients to date. In March 2009, Spectral obtained the exclusive development and commercial rights in the U.S. for PMX, and in November 2010, signed an exclusive distribution agreement for this product in Canada. Approximately 330,000 patients are diagnosed with severe sepsis and septic shock in North America each year. Spectral, through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a new proprietary platform, SAMI, targeting the renal replacement therapy (RRT) market. Dialco is also seeking regulatory approval for in-home use of DIMI which is based on the same RRT platform, but will be intended for home hemodialysis use. DIMI recently received its FDA 510k clearance for use in hospital and clinical settings. Spectral is listed on the Toronto Stock Exchange under the symbol EDT. For more information, please visit www.spectraldx.com.
Comment by daviking on Mar 02, 2021 8:56am
Will Kellum make a difference or will the company have to get on a higher stock exchange so that investors/groups/funds could purchase stock. The company partiicipated in this same conference in Sept. 2020 and that didn't do much for exposure if you look at volume and price. I checked to make sure, cuz, I thought I recognized that name. While checking on the corporate update of last August, I ...more  
Comment by mercedesman on Mar 02, 2021 10:02am
"Some elgitimate comments and questions but I'm sure one of the alter egos will prononce me a basher/Beech boy because of that" -dVkg No ...but I will pronounce you a poster with bad spelling habits, and a flare for the pessimism...unlike say STT, who is a poster with bad spelling, and a flare for optimism. Can't blame you I guess, given your buy-in 20 years ago at $ 3 - $ 4 ...more  
Comment by daviking on Mar 02, 2021 10:26am
That's the best you can do and focus on in first comment in your reply? Didn't know you were a Grad School teacher and are on people for hitting a keytoo fast. What about you, (only took two posts rereads to find the same "error": "FVI, PAAS and FR have all done well, even with the recent pull-back in the PoG. FR got caught up in the Reddit thing beleive it or not." To ...more  
Comment by mercedesman on Mar 02, 2021 10:54am
Davi Take some calming medication/herbs/tea...you are so sensitive. And thx for pointing out my spelling mistakes. I will try to do better. I'm glad you loaded up at .20 ...very precient of you !  All whilst Spectral was trading at its absolute lows...you did better any and all of the insiders !  Congrats!    You really saw the value after the Oct 2016 calamity. MM PS ...more  
Comment by daviking on Mar 02, 2021 12:08pm
Jeez, MM, you just can't stop yourself, can you! Oh, but I forgot, that you have a delusional disorder, that manifests itself with multiple personalities. My suggestion is that you continue your psycotherapy or try Thorazine. Delusional because you keep answering/commenting on your alter egos post (STT, IG. and in the past SWYG, Georgieboy, schemehatcher and ???). Delusional in that because I ...more  
Comment by mercedesman on Mar 02, 2021 1:59pm
It's not something that you should be ashamed of Daviking.  Being in a stock for 20 years just means that you are a buy and holder (or b-holder for short).   Buffet did well with that strategy (mind you he probably has a better picker than you...or even me for that matter). BTW the 20 yr chart says that Spectral was  almost exactly $ 4 back when you came aboard.  ...more  
Comment by daviking on Mar 02, 2021 2:12pm
Wow, you keep talking through your hat. Didn't realize I could rent space in your head for FREE? Any chance you coud comment on how much good  it will do for Spectral to be part of the Conference I referred to at the beginning of the morning (given they did the same last September and not much interest)?
Comment by mercedesman on Mar 02, 2021 2:47pm
I've never been a big Wainwright conference fan.  Conferences haven't seemed to much help Spectral in the past. Not sure though, that they gave it  "the old college" try in the past. Maybe this year they will feature JK as a presenter? ...and it will be market moving? He's a draw...  Kellum is to Blood purification & kidney disease as Elon Musk is to ...more  
Comment by oilandgasman on Mar 03, 2021 9:49am
Love the soft bash Paul, you Crafty fuktard
Comment by Domino55 on Mar 03, 2021 10:01am
That is a valuable contribution Oil. Wow! Rev you might be in to something. 400K seems a bit light to me, so maybe he is in line for a second granting of options. Or maybe his salary is higher than we are considering.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities